Veeva Systems (VEEV) stock saw a welcome improvement to its Relative Strength (RS) Rating on Wednesday, rising from 68 to 72.
↑ XIBD's proprietary RS Rating identifies market leadership by using a 1 (worst) to 99 (best) score that indicates how a stock's price performance over the last 52 weeks compares to the rest of the market.
Decades of market research reveals that the stocks that go on to make the biggest gains tend to have an 80 or higher RS Rating as they begin their largest climbs. See if Veeva Systems stock can continue to rebound and clear that threshold.
Can You Really Time The Stock Market?
Veeva System stock cleared a cup-with-handle pattern with a 226.47 entry point back in November. Since then, it's pulled back slightly and not an ideal time to jump in since it isn't near a proper buy zone, but see if the stock goes on to form a base and break out.
The cloud-based software company for life science industry reported 31% EPS growth in the latest quarterly report, while sales growth came in at 13%.
Veeva Systems stock earns the No. 4 rank among its peers in the Computer Software-Medical industry group. Doximity (DOCS) is the top-ranked stock within the group.
YOU MAY ALSO LIKE:
Learn How To Time The Market With IBD's ETF Market Strategy
Find Today's Best Growth Stocks To Watch With IBD 50
Find The Best Long-Term Investments With IBD Long-Term Leaders
How To Research Growth Stocks: Why This IBD Tool Simplifies The Search For Top Stocks
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。